TNF and interstitial lung disease: Some studies suggest that specific biologics, such as TNF inhibitors, may worsen pulmonary diseases in high-risk patients, mainly those with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) [11].